Dr. Reddy's Research & Development B.V.

Over time, OctoPlus started to focus more and more on complex injectables and from the year 2000 onwards, the company moved to its own facility. OctoPlus started to develop its own drug delivery technologies, mostly in the area of depot injections based on polymers. Since 2013, OctoPlus is part of Dr. Reddy’s one of the world’s leading generic companies.